JONES WILLIAM A JR
SEC insider (Form 3/4/5 filer). CIK 0001373097. Director at Apogee Therapeutics, Inc. (APGE) and 3 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2026. Located in SAN FRANCISCO, CA.
Companies JONES WILLIAM A JR has filed insider reports for
- Apogee Therapeutics, Inc. (APGE): Director
- Apnimed, Inc. (APMD): Director
- Annexon, Inc. (ANNX): Director
- NewAmsterdam Pharma Co N.V. (NAMS): Officer, Chief Commercial Officer
JONES WILLIAM A JR
CIK: 0001373097
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Sep 3, 2026APGE
Apogee Therapeutics, Inc.
DispositionDirect34.8K shares- - Aug 3, 2026APMD
Apnimed, Inc.
AwardDirectStock Option (Right to Buy)
44.5K shares- - Aug 3, 2026APMD
Apnimed, Inc.
DispositionDirectStock Option (Right to Buy)
44.5K shares- - Jul 30, 2026APMD
Apnimed, Inc.
AwardDirectStock Option (Right to Buy)
44.5K shares- - Jun 11, 2026ANNX
Annexon, Inc.
AwardDirectStock Option (Right to Buy)
65K shares- - Jun 9, 2026APGE
Apogee Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
7.7K shares- - Jun 17, 2025APGE
Apogee Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
14.5K shares- - Jun 5, 2025ANNX
Annexon, Inc.
AwardDirectStock Option (Right to Buy)
55K shares- - Jan 9, 2025ANNX
Annexon, Inc.
AwardDirectStock Option (Right to Buy)
88K shares- - Jan 7, 2025NAMS
NewAmsterdam Pharma Co N.V.
AwardDirect43K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 3, 2026 |  APGE Apogee Therapeutics, Inc. | Disposition | 34,824 | - | $0 | Direct |
| Aug 3, 2026 |  APMD Apnimed, Inc. | Award Stock Option (Right to Buy) | 44,477 | - | - | Direct |
| Aug 3, 2026 | APMD Apnimed, Inc. | Disposition Stock Option (Right to Buy) | 44,477 | - | - | Direct |
| Jul 30, 2026 | APMD Apnimed, Inc. | Award Stock Option (Right to Buy) | 44,477 | - | - | Direct |
| Jun 11, 2026 |  ANNX Annexon, Inc. | Award Stock Option (Right to Buy) | 65,000 | - | - | Direct |
| Jun 9, 2026 | APGE Apogee Therapeutics, Inc. | Award Stock Option (Right to Buy) | 7,657 | - | - | Direct |
| Jun 17, 2025 | APGE Apogee Therapeutics, Inc. | Award Stock Option (Right to Buy) | 14,461 | - | - | Direct |
| Jun 5, 2025 | ANNX Annexon, Inc. | Award Stock Option (Right to Buy) | 55,000 | - | - | Direct |
| Jan 9, 2025 | ANNX Annexon, Inc. | Award Stock Option (Right to Buy) | 88,000 | - | - | Direct |
| Jan 7, 2025 |  NAMS NewAmsterdam Pharma Co N.V. | Award | 43,000 | - | $0 | Direct |
1-10 of 11 transactions